Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
NBP
Stock Latest News
Company Announcements
NovaBridge Biosciences Names Veteran Deal-Maker Mark Hagler President and CCO to Steer Late-Stage Oncology and Eye-Drug Push
9d ago
6K
NBP
Premium
Company Announcements
NovaBridge Biosciences Highlights 2025 Results and Advances Late-Stage Oncology and Ophthalmology Programs
23d ago
6K
NBP
Premium
Pre-Earnings
IMAB Upcoming Earnings Report: What to Expect?
1M ago
NBP
Premium
Company Announcements
NovaBridge Wins FDA Backing for Accelerated Approval Pathway for Givastomig in Gastric Cancer
2M ago
6K
NBP
Premium
The Fly
NovaBridge had ‘productive’ FDA meeting on potential gastric cancer treatment
2M ago
NBP
Premium
Company Announcements
NovaBridge and Visara Post Strong VIS-101 Phase 2a Wet AMD Data, Plot Path to Late-Stage Trials
2M ago
6K
NBP
Premium
The Fly
NovaBridge, Visara announce results from VIS-101 Phase 2a Wet AMD study
2M ago
NBP
Premium
Company Announcements
NovaBridge Biosciences Sets March 9 Call to Review Phase 2a VIS-101 Data in Wet AMD
2M ago
6K
NBP
Premium
Company Announcements
NovaBridge Biosciences Unveils February Investor Deck Detailing Global Hub-and-Spoke Biotech Strategy
2M ago
6K
NBP
Premium
The Fly
NovaBridge appoints Cunningham as Vice Chairman of Board of Directors
2M ago
NBP
Premium
Company Announcements
NovaBridge Biosciences Names Emmett Cunningham Vice Chairman to Bolster Biotech Platform
2M ago
6K
NBP
Premium
The Fly
NovaBridge enrolls first patient in givastomig combination study
2M ago
NBP
Premium
Company Announcements
NovaBridge Doses First Patient in Global Phase 2 Gastric Cancer Trial of Givastomig
2M ago
6K
NBP
Premium
The Fly
Amazon downgraded, Roblox upgraded: Wall Street’s top analyst calls
3M ago
EL
PI
Premium
Company Announcements
NovaBridge Biosciences Unveils February 2026 Investor Presentation Highlighting Global Hub-and-Spoke Biotech Strategy
3M ago
6K
NBP
Premium
Ratings
Reaffirming Buy on NovaBridge Biosciences: Differentiated Givastomig Profile, Expanded Patient Reach, and Strengthened Long-Term Value Proposition
3M ago
NBP
Premium
The Fly
NovaBridge resumed with a Buy at H.C. Wainwright
3M ago
NBP
Premium
Company Announcements
NovaBridge CEO Begins Open-Market Purchases of Company ADSs
3M ago
6K
NBP
Premium
Company Announcements
NovaBridge Biosciences Executive Begins Open-Market ADS Purchases
3M ago
6K
NBP
Premium
The Fly
NovaBridge announces open market purchases by executive chairman Fu Wei
3M ago
NBP
Premium
Company Announcements
NovaBridge Biosciences Executive Chairman Begins Up to $5 Million Open-Market ADS Purchase
3M ago
6K
NBP
Premium
Ratings
Reiterating Buy on NovaBridge: Strong Phase 1b Givastomig Data, Manageable Safety, and Attractive Entry Point Support $9 Target
4M ago
NBP
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
